Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Were Hedge Funds Right About CVS Health Corporation (CVS)?

The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a torrid quarter, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards CVS Health Corporation (NYSE:CVS).

Is CVS Health Corporation (NYSE:CVS) a healthy stock for your portfolio? Hedge funds are in an optimistic mood. The number of long hedge fund bets went up by 28 lately. Our calculations also showed that CVS is among the 30 most popular stocks among hedge funds, ranking 22nd. CVS was in 77 hedge funds’ portfolios at the end of the fourth quarter of 2018. There were 49 hedge funds in our database with CVS holdings at the end of the previous quarter.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 32 percentage points since May 2014 through March 12, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 27.5% through March 12, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

GLENVIEW CAPITAL

We’re going to take a peek at the key hedge fund action surrounding CVS Health Corporation (NYSE:CVS).

How are hedge funds trading CVS Health Corporation (NYSE:CVS)?

At the end of the fourth quarter, a total of 77 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 57% from the second quarter of 2018. By comparison, 50 hedge funds held shares or bullish call options in CVS a year ago. So, let’s review which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

CVS_mar2019

The largest stake in CVS Health Corporation (NYSE:CVS) was held by Glenview Capital, which reported holding $556.3 million worth of stock at the end of September. It was followed by Diamond Hill Capital with a $341.3 million position. Other investors bullish on the company included Millennium Management, Owl Creek Asset Management, and Adage Capital Management.

As one would reasonably expect, key hedge funds have jumped into CVS Health Corporation (NYSE:CVS) headfirst. Adage Capital Management, managed by Phill Gross and Robert Atchinson, assembled the most outsized position in CVS Health Corporation (NYSE:CVS). Adage Capital Management had $106.1 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also made a $86.7 million investment in the stock during the quarter. The other funds with new positions in the stock are Farallon Capital, Samuel Isaly’s OrbiMed Advisors, and Josh Donfeld and David Rogers’s Castle Hook Partners.

Let’s now review hedge fund activity in other stocks similar to CVS Health Corporation (NYSE:CVS). We will take a look at United Parcel Service, Inc. (NYSE:UPS), Banco Santander (Brasil) SA (NYSE:BSBR), NextEra Energy, Inc. (NYSE:NEE), and Rio Tinto Group (NYSE:RIO). This group of stocks’ market caps are similar to CVS’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
UPS 32 1158324 1
BSBR 10 170883 3
NEE 37 943957 5
RIO 23 1143298 3
Average 25.5 854116 3

View table here if you experience formatting issues.

As you can see these stocks had an average of 25.5 hedge funds with bullish positions and the average amount invested in these stocks was $854 million. That figure was $2831 million in CVS’s case. NextEra Energy, Inc. (NYSE:NEE) is the most popular stock in this table. On the other hand Banco Santander (Brasil) SA (NYSE:BSBR) is the least popular one with only 10 bullish hedge fund positions. Compared to these stocks CVS Health Corporation (NYSE:CVS) is more popular among hedge funds. Our calculations showed that top 15 most popular stocks among hedge funds returned 19.7% through March 15th and outperformed the S&P 500 ETF (SPY) by 6.6 percentage points. Unfortunately CVS wasn’t in this group. Hedge funds that bet on CVS were disappointed as the stock lost 14.5% and underperformed the market. If you are interested in investing in large cap stocks, you should check out the top 15 hedge fund stocks as 13 of these outperformed the market.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...